It has been suggested that (i) mTORC1 inhibition synergizes with ferroptosis inducers to suppress tumor growth [31], (ii) mTORC1 inhibition decreases GPX4 levels [30, 31] and (iii) RSL3 blocks mTOR activation [30]. Here, GPX4 is linked to neoplasm.